Background Currently, it is estimated that 1 in 800 live births worldwide has Down syndrome (DS). In addition to the relationship with intellectual disability, DS is directly associated with a group of clinical manifestations resulting from premature aging, and may present patterns of comorbidities similar to those found in the elderly. Therefore, together with the greater number of years lived, there is an increased risk of developing Alzheimer's disease (AD) in DS, especially with regard to the interaction between pathogenic mechanisms related to cerebral amyloidogenesis and factors inherent to premature aging. Thus, this study aimed to investigate biological markers of AD in peripheral blood samples from adults and elderly individuals with DS and to compare them with individuals with normal karyotype, stratifying the groups according to the presence or absence of cognitive impairment. Method A total sample of 123 individuals was recruited. The experimental group consisted of 31 adults and elderly individuals with DS. Two comparative groups were categorized according to euploid individuals (EU), being 23 elderly with AD (EUAD) and 69 adults with normal cognition (EUNC). The DS group was subclassified according to the occurrence of cognitive decline, DS without evidence of cognitive decline (DSNC) and DS with cognitive decline (DSAD). AD biomarkers were determined in platelets, including the Amyloid Precursor Protein ratio (APPr), established by the ratio between the 130‐ and 110kDA secreted peptides (sAPP), as well as the protein expression of APP‐secretases α (ADAM‐10), β (BACE‐1) and γ (PSEN1). Result The comparison between DSNC vs. EUNC, showed lower protein expression of APP secretases among individuals with DS. When observed groups with cognitive decline (i.e., DSAD vs. EUAD), the DSAD group showed lower expression of APP130 and 110kDa and BACE1 fragments, as well as increased levels of APPr compared to EUAD. It was also observed a 2.5‐fold decrease expression of APP130 in SDAD, compared to SDNC. Conclusion These results demonstrate that people with DS may show different expression patterns of proteins involved in the amyloid cascade, detectable even in the absence of cognitive decline. However, more analysis is needed for these data to be confirmed.
Background:The Down syndrome (DS) is a genetic disturb caused for the trisomy of chromosome 21. It is the most common cause of intellectual disability, in addition DS accelerates aging and others development and health problems. Some pathological aspects, common to DS with dementia and Alzheimer disease (AD) suggest com-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.